Brief: Sprint Bioscience Q3 Operating Loss Narrows To SEK 12.5 Mln

Sprint Bioscience AB

26/10/2022 06:39

Oct 26 (Reuters) - Sprint Bioscience AB  SPRINT.ST :
    * Q3 NET SALES SEK 0 MLN VS SEK 34.3 MLN YR AGO
    * Q3 OPER LOSS SEK 13.5 MLN VS PROFIT SEK 17.3 MLN YR AGO

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nMFN15h2dd
 Further company coverage:  SPRINT.ST  
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))